Slate Medicines, Inc. funding
Slate Medicines, Inc., a pharmaceuticals company based in Boston, MA (founded 2024), filed a Form D with the SEC on March 11, 2026 and reported $10M raised of a $130M offering.
Amount raised$10M
Offering size$130M
Filed with the SECMarch 11, 2026
First saleFebruary 17, 2026
IndustryPharmaceuticals
SecuritiesEquity, Options or warrants, Security to be acquired on exercise
LocationBoston, MA
Founded2024
Entity typeCorporation
Investors so far6
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Mar 11
Other health care rounds in Massachusetts
Zai Lab Ltd$250M · Nov 9BiotechnologyTypewriter Therapeutics, Inc.$56.3M · Sep 21BiotechnologyAI3 Bio, Inc.$48.3M · Nov 4BiotechnologyNanopath Inc$29.9M · Nov 13BiotechnologyXRHealth, Inc.$22.8M · Sep 16Other Health CareXact Bio, Inc.$10M · Sep 28BiotechnologyCrosslink Therapeutics Inc.$5.5M · Oct 20PharmaceuticalsFresenius Medical Care Fulshear, LLC$4.4M · Oct 21Other Health Care